Botulinum Toxin for Forehead

Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

Today botulinum toxin is considered a gold standard cosmetic procedure for the frontal lines, and although different brands have been introduced to the market, understanding the individual mimics and real muscle extension lead to a differentiated natural outcome. For good and beautiful features, the patient must be evaluated dynamically and other issues must be considered such as the brow level, the facial and rhytids asymmetry as well as muscle hypertrophy and extension. Based on these individuality, the doctor might be comfortable to rapidly classify the lines and predict the distribution of the sites to determine the amount of botulinum toxin to be injected to each one. The physician’s aim is a natural look and a long-term treatment, not only to minimize the rhytids, but to prevent the deep forehead lines. Different clinical presentations require an individual analysis and planning to show different results between highly trained professionals and non-physicians.

Keywords

Botulinum Toxin Forehead Frontal Forehead Lines Rhytids 

References

  1. Braz AV, Sakuma TH. Patterns of contraction of the frontalis muscle: a pilot study. Surg Cosmet Dermatol. 2010;2(3):191–4.Google Scholar
  2. Carruthers J, Fagien S. Matarasso SL; Botox consensus group. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg. 2004;114(6 Suppl):1S–22S.CrossRefPubMedGoogle Scholar
  3. Cox SE, Finn JC, Stetler L, Mackowiak J, Kowalski JW. Development of the facial lines treatment satisfaction questionnaire and initial results for botulinum toxin type A-treated patients. Implications of facial lines. Dermatol Surg May. 2003;29(5):444–9; discussion 449CrossRefGoogle Scholar
  4. Dubina M, Tung R, Bolotin D, Mahoney AM, Tayebi B, Sato M, Mulinari-Brenner F, Jones T, West DP, Poon E, Nodzenski M, Alam M. Treatment of forehead/glabellar rhytides complex with combination botulinum toxin A and hyaluronic acid versus botulinum toxin A injection alone: a split face, rater-blinded, randomized control trial. J Cosmetic Dermatol. 2013;12(4):261–6.CrossRefGoogle Scholar
  5. Finn JC, Ellen-Cox S. Practical anatomy of botulinum toxin. In: Carruthers A, Carruthers J, editors. Botulinum toxin. Rio de Janeiro: Elsevier; 2005. p. 19–30.Google Scholar
  6. Gordin EA, et al. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study. JAMA Facial Plast Surg. 2014;16(3):193–8. doi: 10.1001/jamafacial.2013.2458.CrossRefPubMedGoogle Scholar
  7. Lorenc ZP, et al. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type a therapy. Aesthet Plast Surg. 2013;37(5):975–83. doi: 10.1007/s00266-013-0178-1.CrossRefGoogle Scholar
  8. Steinsapir KD, Rootman D, Wulc A, Hwang C. Cosmetic Microdroplet Botulinum Toxin A Forehead Lift: A New Treatment Paradigm. Ophthal Plast Reconstr Surg. 2015;31(4):263–8. doi:  10.1097/IOP.0000000000000282 CrossRefPubMedGoogle Scholar
  9. Tamura BM. Padronização dos pontos musculares da região frontal e glabelar. In: Doris Hexsel, Ada Trindade de Almeida. (Org.). Uso cosmético da toxina botulínica, vol. 1. 1st ed. Porto Alegre: AGE Editora; 2002. p. 145–8.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Rio de JaneiroBrazil

Personalised recommendations